European Archives - Page 705 of 1303 - European Medical Journal

EADV 2021 Janssen-Sponsored Virtual Satellite Symposium: 'The Dermatologist’s Guide to the Clearance of the Skin'

A review of the Janssen-sponsored virtual satellite symposium titled: ‘The dermatologist’s guide to the clearance of the skin.’

Can Liver Cancer Immunotherapy Efficacy Be Improved Through Novel Approaches?

Sought to increase the efficacy of immunotherapy in patients with liver cancer by treatment in combination with adjuvant therapies…

The Cycle of Neurodegeneration in the Liver Associated with Fatty Liver Disease

Evidence has further shown a direct correlation between the severity of liver pathology and the level of nerve degeneration…

Janssen-Sponsored EADV 2021 Highlights

This Janssen-sponsored podcast explores highlights from EADV 2021. Hear from Professor Matthias Augustin and Professor Ulrich Mrowietz.

The Clinical and Therapeutic Implications of Meal Replacements: Sustained Weight Loss for Improved Liver Health and Diabetes Remission

Ard opened his talk by discussing the role of nutrition in T2DM. For some individuals, T2DM is a consequence of excess weight gain. The…

EMJ Diabetes 9 [Supplement 2] 2021

A symposium presented at the Obesity Week 2021 Virtual Meeting saw presentations from experts Jamy Ard, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA, and Wajahat Mehal, Yale University, New Haven, Connecticut, USA. Ard discussed the benefits of meal replacements, presenting data evidencing the associated increased rates of Type 2 diabetes mellitus remission.

A Shifting System

This week, Jonathan speaks with Bruce Gingles, Founder, Business, Entrepreneurship, Science & Technology (BEST).

EMJ Hematology 9 [Supplement 7] 2021

Cutaneous T cell lymphoma (CTCL) is a rare type of non-Hodgkin lymphoma that develops in the T cells. Mycosis fungoides (MF) and Sézary…

Optimising Outcomes in Cutaneous T Cell Lymphoma: Role of Blood Involvement and Treatment Options

CTCL is a rare type of non-Hodgkin lymphoma, primarily presenting in the skin but with extracutaneous involvement in some patients. Around…

Catherine Owen

Catherine Owen on the future of data

Catherine Owen, Head of Major Markets at Bristol Myers Squibb, discusses upcoming changes to pharma’s data policies.